| |
| |
|
| Insider
Information: |
Levin Arthur A |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
16,504 |
|
|
Indirect Shares
|
271,851 |
|
|
| Direct
Value |
$450,407 |
|
|
|
Indirect Value
|
$6,590,517 |
|
|
| Total
Shares |
288,355 |
|
|
| Total
Value |
$7,040,924 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 35.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Vice President |
2007-04-25 |
1,674 |
2003-07-01 |
0 |
Premium* |
|
|
Stoke Therapeutics, Inc. |
STOK |
Director |
2021-03-01 |
0 |
2021-03-01 |
17,979 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
Director |
2024-04-19 |
14,830 |
2024-04-19 |
253,872 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
69 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| STOK |
Stoke Therapeutics, Inc. |
Director |
– • – |
2021-03-01 |
4 |
AS |
$60.55 |
$759,841 |
D/D |
(12,500) |
0 |
0 |
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-03-16 |
4 |
AS |
$27.87 |
$128,181 |
D/D |
(4,600) |
0 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
officerTitle |
• – – |
2003-07-01 |
4 |
A |
$4.39 |
$1,090 |
D/D |
248 |
778 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
VP, Development |
• – – |
2004-01-01 |
4 |
A |
$4.46 |
$1,972 |
D/D |
442 |
1,220 |
|
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-06-17 |
4 |
AS |
$27.75 |
$5,550 |
D/D |
(200) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-06-24 |
4 |
AS |
$27.76 |
$2,776 |
D/D |
(100) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-06-25 |
4 |
AS |
$27.97 |
$565,299 |
D/D |
(20,100) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-08-12 |
4 |
AS |
$22.00 |
$308,066 |
D/D |
(14,003) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-08-15 |
4 |
AS |
$22.12 |
$1,382,343 |
D/D |
(62,498) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-08-16 |
4 |
AS |
$22.08 |
$77,257 |
D/D |
(3,499) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2022-12-29 |
4 |
AS |
$22.01 |
$880,568 |
D/D |
(40,000) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2023-01-12 |
4 |
AS |
$22.00 |
$220,028 |
D/D |
(10,000) |
1,330 |
0 |
% |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-06-24 |
4 |
OE |
$1.24 |
$124 |
D/D |
100 |
1,430 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2004-07-01 |
4 |
A |
$4.86 |
$1,322 |
D/D |
272 |
1,492 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2004-12-03 |
4 |
AS |
$6.32 |
$30,429 |
D/D |
(4,817) |
1,492 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2004-12-09 |
4/A |
AS |
$6.15 |
$18,450 |
D/D |
(3,000) |
1,492 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2004-12-10 |
4 |
AS |
$6.15 |
$34,010 |
D/D |
(5,500) |
1,492 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2004-12-22 |
4 |
AS |
$6.20 |
$6,200 |
D/D |
(1,000) |
1,492 |
|
- |
|
| RNA |
Avidity Biosciences, Inc. |
Chief Scientific Officer |
• – – |
2021-06-17 |
4 |
OE |
$1.24 |
$248 |
D/D |
200 |
1,530 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2005-01-01 |
4 |
A |
$4.67 |
$849 |
D/D |
182 |
1,674 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-02-16 |
4 |
AS |
$7.95 |
$23,850 |
D/D |
(3,000) |
1,674 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-02-17 |
4 |
AS |
$8.03 |
$62,393 |
D/D |
(7,770) |
1,674 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-03-20 |
4 |
AS |
$8.96 |
$85,860 |
D/D |
(9,500) |
1,674 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-03-21 |
4 |
AS |
$9.00 |
$4,513 |
D/D |
(500) |
1,674 |
|
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Vice President |
• – – |
2006-10-06 |
4 |
AS |
$7.95 |
$79,736 |
D/D |
(10,000) |
1,674 |
0 |
- |
|
69 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
